v3.26.1
STOCKHOLDERS' DEFICIT (Tables)
6 Months Ended
Jun. 30, 2026
STOCKHOLDERS' DEFICIT  
Summary of the Company's option activity

For the Six months ended

June 30, 2026

  ​ ​ ​

  ​ ​ ​

Weighted

  ​ ​ ​

 

average

Aggregate

Amount of

exercise

intrinsic

options *

price

value

$

$

Outstanding at December 31, 2025

 

51,656

34.19

 

Granted

 

1,512,500

0.70

 

Cancelled

 

(2,978)

13.22

 

Outstanding at June 30, 2026

 

1,561,178

1.78

 

Exercisable at June 30, 2026

 

802,387

2.61

 

*   Represents Employee Stock Options only (not including RSUs).

Schedule of restricted stock activity

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted Average

Remaining

Number of Shares

Weighted Average

Contractual

of Restricted

Grant Date Fair

Term

Stock

Value

(Years)

Nonvested as of December 31, 2025

 

310,854

3.01

 

0.45

Granted

 

2,680,000

0.70

 

Vested

 

1,647,604

1.07

 

Forfeited

 

 

Nonvested as of June 30, 2026

 

1,343,250

 

0.78

 

0.16

Schedule of total stock-based compensation expense

Six months ended

June 30,

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

466

$

247

General and administrative

1,911

470

Total stock-based compensation expense

$

2,377

$

717